Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacs (PACS) Cash & Equivalents (2023 - 2025)

Pacs (PACS) has disclosed Cash & Equivalents for 3 consecutive years, with $197.0 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 24.95% to $197.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $197.0 million through Dec 2025, up 24.95% year-over-year, with the annual reading at $197.0 million for FY2025, 24.95% up from the prior year.
  • Cash & Equivalents hit $197.0 million in Q4 2025 for Pacs, down from $355.7 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $355.7 million in Q3 2025 to a low of $38.2 million in Q2 2023.
  • Historically, Cash & Equivalents has averaged $147.6 million across 3 years, with a median of $87.7 million in 2023.
  • Biggest five-year swings in Cash & Equivalents: fell 28.33% in 2024 and later surged 618.25% in 2025.
  • Year by year, Cash & Equivalents stood at $73.4 million in 2023, then soared by 114.77% to $157.7 million in 2024, then grew by 24.95% to $197.0 million in 2025.
  • Business Quant data shows Cash & Equivalents for PACS at $197.0 million in Q4 2025, $355.7 million in Q3 2025, and $294.2 million in Q2 2025.